<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A <z:e sem="disease" ids="C0041364" disease_type="Disease or Syndrome" abbrv="">tumor lysis syndrome</z:e> with hyperkalaemia, <z:e sem="disease" ids="C0085681" disease_type="Disease or Syndrome" abbrv="">hyperphosphataemia</z:e>, <z:hpo ids='HP_0002149'>hyperuricaemia</z:hpo> and <z:hpo ids='HP_0002901'>hypocalcaemia</z:hpo> developed 48 hours after start of combined <z:chebi fb="0" ids="35610">cytostatic</z:chebi> treatment in a 16-year-old boy with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Despite prophylactic administration of <z:chebi fb="0" ids="40279">allopurinol</z:chebi> and urinary alkalization, postrenal precipitation of urates and <z:chebi fb="0" ids="9679">calcium phosphate</z:chebi> caused <z:hpo ids='HP_0001919'>acute renal failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Ureteric splinting and percutaneous fistulization of the contralateral renal pelvis became necessary </plain></SENT>
<SENT sid="3" pm="."><plain>Elevated renal retention values became <z:mpath ids='MPATH_458'>normal</z:mpath> after these measures and infusions with balanced alkalized electrolyte solutions, and the <z:hpo ids='HP_0002901'>hypocalcaemia</z:hpo> was counteracted </plain></SENT>
</text></document>